Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P120002/S036

S.M.A.R.T. and S.M.A.R.T. CONTROL Vascular Stent Systems; S.M.A.R.T. RADIANZ Vascular Stent System

Cordis US Corporation · Decision date Oct 15, 2026

MEDTECHLEDGER EXPLANATIONP120002/S036

What did the FDA decide?

The FDA recorded a 30-Day Notice decision (OK30) dated 2026-10-15 for P120002/S036, a supplement to the S.M.A.R.T. and S.M.A.R.T. CONTROL Vascular Stent Systems and the S.M.A.R.T. RADIANZ Vascular Stent System, submitted by Cordis US Corporation. The supplement type is a 30-Day Notice, and the recorded reason is a process change involving a manufacturer, sterilizer, packager or supplier.

The recorded statement covers approval for an alternate supplier of a Bismuth Sub Carbonate Blend used in the catheter outer member. This is a supply-chain change to one catheter component, not a new approval of the stent systems as a whole. The source does not describe the blend's function, the prior supplier, or any testing submitted, so the basis for the decision and any labeling effect remain unknown.

The device category is a superficial femoral artery stent (product code NIP) in the cardiovascular specialty. The record does not state clinical indications, patient-selection criteria or performance data, and none should be inferred from this supplement.

FDA approval order statement

approval for an alternate supplier of a Bismuth Sub Carbonate Blend used in the catheter outer member
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 15, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P120002/S036
Regulatory pathway
PMA supplement
Product code
NIP
Decision code
OK30
Decision date
Oct 15, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: STENT, SUPERFICIAL FEMORAL ARTERY.

Product code
NIP
FDA device class
3

For the original device and its historical approval scope, see PMA P120002. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P120002 · Original PMA

    SMA RT CONTROL AND SMART VASCULAR STENT SYSTEMS

  2. P120002/S036 received

    Application receipt date recorded by FDA.

  3. P120002/S036 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P120002. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P120002

Product / regulatory recordCompanyPathwayDecision dateSource
Cordis US CorporationPMA approvalNov 7, 2012FDA

Explore the linked device profile

Other records with product code NIP

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cordis US Corporation

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
14201 NW 60th Ave., Miami Lakes, FL, 33014

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records